Related Experiment Video

Updated: May 29, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment

Rana Elkholi1, Konstantinos V Floros, Jerry E Chipuk

  • 1Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY, USA.

Genes & Cancer
|September 9, 2011
PubMed

Insights

Tumor cells resist apoptosis by blocking mitochondrial pathways. This review explores BH3-only proteins and BH3 mimetics, which enhance cancer cell death sensitivity for therapeutic potential.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Tumor cells evade apoptosis, a programmed cell death, through complex regulatory mechanisms.
  • The mitochondrial pathway of apoptosis is crucial, involving BCL-2 family proteins that control outer mitochondrial membrane integrity.
  • BH3-only proteins are key regulators within the BCL-2 family, influencing apoptosis induction.

Purpose of the Study:

  • To review the cellular and pharmacological regulation of BH3-only proteins.
  • To elucidate signaling pathways and agents targeting BH3-only proteins.
  • To discuss the development and clinical application of small-molecule BH3 mimetics.

Main Methods:

  • Literature review focusing on apoptosis regulation.
  • Analysis of signaling pathways involving BCL-2 family proteins.
  • Examination of small-molecule BH3 mimetic development and clinical trials.

Main Results:

  • BH3-only proteins are critical in sensitizing cells to apoptosis.
  • Dysregulation of BH3-only proteins contributes to cancer cell survival.
  • Small-molecule BH3 mimetics show promise in cancer therapy by reactivating apoptosis.

Conclusions:

  • Targeting BH3-only proteins offers a viable strategy to overcome tumor cell resistance to apoptosis.
  • BH3 mimetics represent a promising class of therapeutics currently in clinical development.
  • Further understanding of BH3-only protein regulation can lead to improved cancer treatments.
Keywords:
BCL-2 familyBH3-only proteinsapoptosiscancermitochondria

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...